Rosmarini folium

Dried leaves of rosemary used phytotherapeutically.

HMPC - Monograph: Traditional-use: Internal: Dyspeptic complaints, mild spasmodic gastrointestinal complaints. External: as a bath additive: mild muscle and joint pain, circulatory complaints.
ESCOP monograph: Internal: improvement of liver and gallbladder function, dyspeptic complaints; external: rheumatic diseases, circulatory complaints, also as an antiseptic for wound healing.
Commission e-monograph: Internal: dyspeptic complaints; external: rheumatic diseases; circulatory complaints.

Empirical medicine: coronary heart disease, functional heart complaints (rosemary oil in heart ointments), loss of appetite, aiding digestion, increasing the secretion of gastric juices, convalescence.

Antibacterial, antiviral, antioxidant, choleretic, spasmolytic (bile ducts, large intestine), when used externally, promotes blood circulation.

According to Commission E for dyspeptic complaints, adjuvant for rheumatic complaints, circulation problems.

Internally as tea; 3-4x/day 1TL (about 2g). Externally as an addition to the bath water: 50g leaves with 2L of water, brew for 15 min, enough for 1 full bath.

Hypersensitivity reactions. Contact allergic reactions are known.

None known; use of the drug should be avoided if pregnancy is present (BfArM): Risk of toxic reaction with miscarriage at higher dosage internally and promotion of blood circulation as a bath additive.

Children under 12 years of age in the absence of data.

A fixed combination of centaury + lovage root + rosemary leaves is commercially available:

• Rosmarini folium (rosemary leaves)
• Centaurii herba
• Levistici radix (lovage root)
• = Canephron ®N Dragees (Adults: 2-2-2(Children: 1-1-1), which is used for recurrent infections in the uro-genital area.

1. al-Sereiti MR et al.(1999) Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol 37:124-130.
2. Amoah SK et al. (2016) Rosmarinic acid-Pharmaceutical and clinical aspects. Planta Med 82:388-406.
3. Ferreira LG et al. (2013) Is rosmarinic acid underestimated as an experimental cardiovascular drug? Acta Cir Bras 28 Suppl 1:83-87.
4. Moore J et al. (2016) Anticancer Effects of Rosemary (Rosmarinus officinalis L.) Extract and Rosemary Extract Polyphenols. Nutrients 17:8.
5. Nabavi SF et al. (2015) The cellular protective effects of rosmarinic acid: from bench to bedside. Curr Neurovasc Res 12:98-105.
6. Ritschel WA et al (1989) Percutaneous absorption of rosmarinic acid in the rat. In: Meth. Exp. Clin. Pharmacol 11: 345-353.
7. Tong LX et al (2014) Nutrition: the future of melanoma prevention? J Am Acad Dermatol 71:151-160.
8. https://arzneipflanzenlexikon.info/rosmarin.php.
9. https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-rosmarinus-officinalis-l-folium_en.pdf
10. Wenigmann M. (2017) Phytotherapy medicinal drugs, phytopharmaceuticals, application. Urban & Fischer, pp. 183-184